Characteristics | RRH group (n = 30) | LRH group (n = 30) | P value |
---|---|---|---|
Agea, yr | 65(62-67) | 64(62-66) | 0.404 |
History of previous abdominal surgeries, n (%) | 12(40.0) | 15(50.0) | 0.436 |
FIGO stages, n (%) | 0.532 | ||
IA | 5(16.7) | 7(23.3) | |
IB1 | 16(53.3) | 14(46.7) | |
IB2 | 1(3.3) | 3(10.0) | |
IIA | 4(13.3) | 4(13.3) | |
IIB | 4(13.3) | 2(6.7) | |
Cell types, n (%) | 0.380 | ||
Squamous | 18(60.0) | 21(70.0) | |
Adenoid | 10(33.3) | 8(26.7) | |
Neuroendocrine | 2(6.7) | 1(3.3) | |
Uterine sizea, cm3 | 153.13(120.00-240.75) | 191.29(147.09-223.62) | 0.352 |
Tumor sizea, cm3 | 4.95(1.43-9.54) | 4.76(2.32-11.9) | 0.767 |
Vaginal lengtha, cm | 1.50(1.00-2.30) | 1.35(1.00-2.00) | 0.337 |
Left pelvic lymph nodesa, n | 9.0(7.0-14.0) | 8.5(6.0-13.0) | 0.727 |
Right pelvic lymph nodesa, n | 10.5(7.0-12.0) | 10.0(7.0-11.0) | 0.541 |
Left pelvic lymph node metastasisa, n | 0(0-0) | 0(0-1.0) | 0.549 |
Right pelvic lymph node metastasisa, n | 0(0-0) | 0(0-0.5) | 0.869 |